HGC Investment Management’s DA32 Life Science Tech Acquisition Corp. Class A Common Stock DALS Stock Holding History

HGC Investment Management’s Portfolio DALS Stock Details DALS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-247,920	Closed	-$2.54M	–	165
2023 Q2	$2.54M	Hold	247,920	–	–	0.92%	29
2023 Q1	$2.51M	Hold	247,920	–	–	0.51%	61
2022 Q4	$2.48M	Buy	+247,920	New	+$2.44M	0.26%	116

HGC Investment Management's DALS Position: Q3 2023 in Review

HGC Investment Management sold out of DA32 Life Science Tech Acquisition Corp. Class A Common Stock (DALS) in Q3 2023, closing a stake of 247,920 shares — an estimated $2.54M sold.

HGC Investment Management first reported a position in DALS in Q4 2022 and held it in 3 quarters. The position peaked at $2.54M in Q2 2023. 0 funds tracked by Wall St. Rank hold DALS as of Q3 2023.

HGC Investment Management reported no remaining DA32 Life Science Tech Acquisition Corp. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
HGC Investment Management sold 247,920 DA32 Life Science Tech Acquisition Corp. Class A Common Stock shares in Q3 2023, an estimated $2.54M.
HGC Investment Management first reported a position in DA32 Life Science Tech Acquisition Corp. Class A Common Stock in Q4 2022 and held it in 3 quarters.
HGC Investment Management's DA32 Life Science Tech Acquisition Corp. Class A Common Stock position peaked at $2.54M in Q2 2023.
0 funds tracked by Wall St. Rank held DA32 Life Science Tech Acquisition Corp. Class A Common Stock as of Q3 2023.

Based on HGC Investment Management's 13F filing for Q3 2023, filed 14 Nov 2023.